Pfizer Declares Second-Quarter 2026 Dividend
Pfizer Inc. announced its board of directors has declared a $0.43 per share cash dividend for the second quarter of 2026. The dividend is payable on June 12, 2026.
New York – Pfizer Inc. (NYSE: PFE) announced on Wednesday, April 22, 2026, that its board of directors has declared a cash dividend of $0.43 per share on the company’s common stock for the second quarter of 2026. The dividend is scheduled to be paid on June 12, 2026, to holders of record as of the close of business on May 8, 2026.
This marks Pfizer's 350th consecutive quarterly dividend payment, underscoring a consistent history of returning value to shareholders. The company's dividend policy reflects its financial stability and commitment to its investors.
Pfizer is a global biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and vaccines. The company aims to improve lives and extend life spans through scientific breakthroughs and the application of its global resources.
The company continues its efforts to advance health care worldwide, working to support and expand access to reliable and affordable health care.